Fundz

Deep Blue Medical Advances, Inc. reported raising $295,000 in an initial SEC Form D filing, from an offering of $295,000

PRIVATEAug 30, 2018

Amount Raised

$295,000

$295,000 sold, per SEC Form D (first sale Aug 30, 2018)

Round Type

Venture

DurhamBiotechnologyConsumer Goodsmedical devices

Quick answer

Deep Blue Medical Advances raised $295,000 in a funding round, dated August 30, 2018. Deep Blue Medical Advances is based in Durham, North Carolina, United States.

How much did Deep Blue Medical Advances raise?
Deep Blue Medical Advances raised $295,000 in a funding round on August 30, 2018.
What does Deep Blue Medical Advances do?
Deep Blue Medical Advances, a Duke University spin-out, is transforming hernia repair with its surgeon-invented T-Line® Hernia Mesh, designed to address the high global rates of hernia occurrence and recurrence.
Where is Deep Blue Medical Advances based and how big is it?
Deep Blue Medical Advances is based in Durham, North Carolina, United States. Fundz records about 11 employees.
Who are the decision-makers at Deep Blue Medical Advances?
Fundz holds 2 contacts at Deep Blue Medical Advances, including the Director of Research Development. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Consumer Goods and medical devices around the same time

Companies in the same sectors as Deep Blue Medical Advances that raised within 45 days of this round, from Fundz verified event records.

  • VASCULAR THERAPIES INC raised $12M on October 12, 2018.
  • USBC raised $302K on October 12, 2018.
  • Kantum Pharma, Inc. raised $805K (Seed) on October 12, 2018.
  • Brain Neurotherapy Bio, Inc. raised $600 (Pre-Seed) on October 11, 2018.
  • Axe Compute Inc. raised $2M (Seed) on October 11, 2018.
  • Propanc Biopharma raised $422K (Seed) on October 11, 2018.

Who to call at Deep Blue Medical Advances, and when

A new round usually means Deep Blue Medical Advances is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Deep Blue Medical Advances raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Deep Blue Medical Advances, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Deep Blue Medical Advances. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Deep Blue Medical Advances

Location

701 W. Main St

Durham, North Carolina, United States

About

Deep Blue Medical Advances, a Duke University spin-out, is transforming hernia repair with its surgeon-invented T-Line® Hernia Mesh, designed to address the high global rates of hernia occurrence and recurrence. Featuring integral suture-like extensions, the mesh eliminates a key failure point in conventional fixation—the mesh-suture-tissue interface—while providing superior anchor strength. With additional products in development, including an anchor clip, a biosynthetic mesh, and a coated composite version, Deep Blue is poised to make a significant impact on the $1.1B global hernia device market by reducing fixation failure and improving surgical outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Deep Blue Medical Advances raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDavid R., Director of Research DevelopmentSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Deep Blue Medical Advances's next move

See what Strategic adds

Deep Blue Medical Advances raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.